Emergence of colistin resistance in Enterobacter aerogenes from Croatia

References

• Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–703.10.1128/AAC.03110-14
   PubMed Web of Science ®Google Scholar
• Arpin C, Coze C, Rogues AM, Gachie JP, Bebear C, Quentin C. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol. 1996;34(9):2163–9.
   PubMed Web of Science ®Google Scholar
• Thiolas A, Bollet C, La Scola B, Raoult D, Pages JM. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother. 2005;1354–8.10.1128/AAC.49.4.1354-1358.2005
   PubMed Web of Science ®Google Scholar
• Bogdanovich T, Adams-Haduch JM, Tian GB, Nguyen MH, Kwak EJ, Muto CA, et al. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis. 2011;53:373–6.10.1093/cid/cir401
   PubMed Web of Science ®Google Scholar
• Mammina C, Bonura C, Bernardo F, Aleo A, Fasciana T, Sodano C, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different ward of an acute general hospital. Eurosurveillance. 2012;17(33):pii20248.
   Web of Science ®Google Scholar
• Cannatelli A, D’Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, et al. In vivo emergence of colistin-resistance in Klebsiella pneumoniae producing KPC-type carbapenemase mediated by insertional inactivation of the phoQ/phOP mgrB regulator. Antimicrob Agents Chemother. 2013;57:5521–6.10.1128/AAC.01480-13
   PubMed Web of Science ®Google Scholar
• Jayol A, Nordmann P, Desroches M, Decousser JW, Poirel L. Acquisition of broad-spectrum cephalosporin resistance leading to colistin resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2016;60(5):3199–201.10.1128/AAC.00237-16
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Giani T, D’Andrea MM, Di Pilato V., Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–703.10.1128/AAC.03110-14
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh T, Yi LX, Zhang R, Spences J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–8.
   PubMed Web of Science ®Google Scholar
• Zeng KJ, Doi Y, Patil S, Huang X, Tian GB. Emergence of the plasmid-mediated mcr-1 gene in colistin-resistant Enterobacter aerogenes and Enterobacter cloacae. Antimicrob Agents Chemother. 2016;60 (6): 3862–3.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI M100-S25. Wayne, PA: CLSI; 2015.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing [EUCAST]. Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group. 2016 March 22. Available from: www.eucast.org
   Google Scholar
• Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867–78.10.1093/clinids/10.4.867
   PubMedGoogle Scholar
• Tan TJ, Yong Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother. 2009;53(1):146–9.10.1128/AAC.00862-08
   PubMed Web of Science ®Google Scholar
• Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15(5):398–402.10.1007/BF01690097
   PubMed Web of Science ®Google Scholar
• Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH. Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995;134(2–3):203–8.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54(4):735–743.10.1093/jac/dkh424
   PubMed Web of Science ®Google Scholar
• Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–62.10.1128/JCM.40.6.2153-2162.2002
   PubMed Web of Science ®Google Scholar
• Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of CTX-M β-lactamases. J Antimicrob Chemother. 2006;57(1):154–5.
   PubMed Web of Science ®Google Scholar
• Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–28.10.1016/j.mimet.2005.03.018
   PubMed Web of Science ®Google Scholar
• Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016; 21(27).
   Google Scholar